Center-Authored Papers

Filters: Author is Pearce, Celeste L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS et al..  2016.  A targeted genetic association study of epithelial ovarian cancer susceptibility.. Oncotarget. 7(7):7381-7389. Abstract
S
Lu Y, Cuellar G, Painter JN, Nyholt D, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D et al..  2015.  Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.. Human molecular genetics. 24(20):5955-5964. Abstract
R
Cannioto RA, Lamonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva AN, Hong C-C, Szender BJ, Sucheston-Campbell L, Joseph JM et al..  2016.  Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.. British journal of cancer. Abstract
P
Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G, Beesley J, Webb PM, Pearce CL, Wu AH, Pike MC et al..  2011.  Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(5):1028-31. Abstract
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ et al..  2016.  PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.. Journal of medical genetics. Abstract
N
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H et al..  2016.  No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. 141(2):386-401. Abstract
M
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE et al..  2013.  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.. Nature genetics. 45(4):371-84,384e1-2. Abstract
Babic A, Harris HR, Vitonis AF, Titus LJ, Jordan SJ, Webb PM, Risch HA, Rossing MA, Doherty JA, Wicklund K et al..  2017.  Menstrual pain and risk of epithelial ovarian cancer: results from the Ovarian Cancer Association Consortium.. International journal of cancer. Abstract
I
Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton-Culver H, Bandera EV, Cramer D, Doherty JA et al..  2016.  Investigation of exomic variants associated with overall survival in ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Reid BM, Permuth JB, Chen AY, Teer JK, Monteiro ANA, Chen Z, Tyrer J, Berchuck A, Chenevix-Trench G, Doherty JA et al..  2017.  Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(1):116-125. Abstract
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM et al..  2015.  Identification of six new susceptibility loci for invasive epithelial ovarian cancer.. Nature genetics. 47(2):164-71. Abstract
Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G et al..  2017.  Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.. Nature genetics. Abstract
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin H-Y, Chen AY, Tsai Y-Y, Qu X et al..  2013.  Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.. Nature communications. 4:1627. Abstract
H
Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender BJ, Segal B, Odunsi K, Mayor P, Diergaarde B et al..  2017.  History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(9):1470-1473. Abstract
G
Pharoah PDP, Tsai Y-Y, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H et al..  2013.  GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.. Nature genetics. 45(4):362-70,370e1-2. Abstract
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA et al..  2013.  Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.. Human genetics. Abstract
Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic W-H et al..  2013.  Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.. Cancer prevention research (Philadelphia, Pa.). 6(8):811-21. Abstract
Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM, Köbel M, Anton-Culver H, Beesley J, Berchuck A, Brar S et al..  2010.  Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(7):1822-30. Abstract
F
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK et al..  2016.  Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.. Nature communications. 7:12675. Abstract
E
Permuth JB, Pirie A, Chen AY, Lin H-Y, Reid BM, Chen Z, Monteiro A, Dennis J, Mendoza-Fandino G, Anton-Culver H et al..  2016.  Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.. Human molecular genetics. Abstract
Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, Defazio A, Gava N, Webb PM, Rossing MA et al..  2010.  Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".. PLoS genetics. 6(7):e1001016. Abstract
Amankwah EK, Lin H-Y, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KKH, Anton-Culver H, Antonenkova N, Bruinsma F et al..  2015.  Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.. Genetic epidemiology. Abstract
Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L et al..  2017.  Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.. British journal of cancer. Abstract
C
Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP et al..  2014.  Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.. Molecular nutrition & food research. Abstract
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM et al..  2015.  Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer.. Carcinogenesis. 36(11):1341-1353. Abstract